| Literature DB >> 26742954 |
Ryoichi Nakamura1, Jun Sone1, Naoki Atsuta1, Genki Tohnai1, Hazuki Watanabe2, Daichi Yokoi1, Masahiro Nakatochi3, Hirohisa Watanabe4, Mizuki Ito1, Jo Senda5, Masahisa Katsuno1, Fumiaki Tanaka6, Yuanzhe Li7, Yuishin Izumi8, Mitsuya Morita9, Akira Taniguchi10, Osamu Kano11, Masaya Oda12, Satoshi Kuwabara13, Koji Abe14, Ikuko Aiba15, Koichi Okamoto16, Kouichi Mizoguchi17, Kazuko Hasegawa18, Masashi Aoki19, Nobutaka Hattori7, Shoji Tsuji20, Kenji Nakashima21, Ryuji Kaji8, Gen Sobue22.
Abstract
We investigated the frequency and contribution of variants of the 28 known amyotrophic lateral sclerosis (ALS)-related genes in Japanese ALS patients. We designed a multiplex, polymerase chain reaction-based primer panel to amplify the coding regions of the 28 ALS-related genes and sequenced DNA samples from 257 Japanese ALS patients using an Ion Torrent PGM sequencer. We also performed exome sequencing and identified variants of the 28 genes in an additional 251 ALS patients using an Illumina HiSeq 2000 platform. We identified the known ALS pathogenic variants and predicted the functional properties of novel nonsynonymous variants in silico. These variants were confirmed by Sanger sequencing. Known pathogenic variants were identified in 19 (48.7%) of the 39 familial ALS patients and 14 (3.0%) of the 469 sporadic ALS patients. Thirty-two sporadic ALS patients (6.8%) harbored 1 or 2 novel nonsynonymous variants of ALS-related genes that might be deleterious. This study reports the first extensive genetic screening of Japanese ALS patients. These findings are useful for developing genetic screening and counseling strategies for such patients.Entities:
Keywords: Amyotrophic lateral sclerosis; Genetic screening; Japan; Next-generation sequencer
Mesh:
Substances:
Year: 2015 PMID: 26742954 DOI: 10.1016/j.neurobiolaging.2015.11.030
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673